Beijing Tongrentang Co Ltd banner

Beijing Tongrentang Co Ltd
SSE:600085

Watchlist Manager
Beijing Tongrentang Co Ltd Logo
Beijing Tongrentang Co Ltd
SSE:600085
Watchlist
Price: 27.94 CNY -0.39% Market Closed
Market Cap: ¥38.3B

Beijing Tongrentang Co Ltd
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Beijing Tongrentang Co Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Tongrentang Co Ltd
SSE:600085
Inventory
¥10.6B
CAGR 3-Years
17%
CAGR 5-Years
12%
CAGR 10-Years
8%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Inventory
¥608.9m
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Inventory
¥2.9B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
19%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Inventory
¥6.2B
CAGR 3-Years
-8%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Zhejiang Nhu Co Ltd
SZSE:002001
Inventory
¥4.5B
CAGR 3-Years
3%
CAGR 5-Years
13%
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Inventory
¥162.2m
CAGR 3-Years
25%
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

Beijing Tongrentang Co Ltd
Glance View

Market Cap
38.3B CNY
Industry
Pharmaceuticals

Nestled in the heart of Beijing's bustling historic district, Beijing Tongrentang Co. Ltd. trace their origins back to 1669 during the Qing Dynasty. This venerable institution has often been heralded as the steward of traditional Chinese medicine (TCM), expertly bridging over three centuries of heritage with the demands of modern healthcare. The company's deep-rooted ethos is centered on the enduring principles of TCM, which emphasize balance and holistic well-being, a philosophy that they have meticulously preserved and adapted over generations. The intricate potions, herbal remedies, and elaborate tonics they craft are derived from a unique blend of ancient recipes and rigorous quality standards, ensuring both authenticity and efficacy. This reverence for tradition, coupled with a commitment to innovation, underpin the strength and credibility of Tongrentang's brand, allowing it to not only maintain but also expand its standing globally. From the cobblestones of Beijing, Tongrentang's operations today encompass a sophisticated network of production facilities, retail outlets, and strategic partnerships, turning the company into a formidable player in the health sector. While steeped in history, this hallmark of traditional Chinese medicine makes its earnings through a modern business model that includes pharmaceuticals, healthcare services, and retail. Their production capabilities boast advanced manufacturing technologies that complement their traditional processes, ensuring scalable and efficient operations without compromising the character of their products. Retail remains a core avenue, with a vast array of stores in China and abroad that serve as conduits for both commerce and education, introducing new generations to TCM. Additionally, Tongrentang has successfully ventured into healthcare services, with clinics providing wellness treatments and consultations that encapsulate the essence of their medicinal philosophy, thus diversifying income streams while deepening consumer engagement with its storied brand.

Intrinsic Value
37.82 CNY
Undervaluation 26%
Intrinsic Value
Price ¥27.94

See Also

What is Beijing Tongrentang Co Ltd's Inventory?
Inventory
10.6B CNY

Based on the financial report for Dec 31, 2025, Beijing Tongrentang Co Ltd's Inventory amounts to 10.6B CNY.

What is Beijing Tongrentang Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
8%

Over the last year, the Inventory growth was -1%. The average annual Inventory growth rates for Beijing Tongrentang Co Ltd have been 17% over the past three years , 12% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett